Roche's New Diabetes Drug Works Better Than Byetta

By wall street journal
Submitted by Amy Tenderich — October 29 at 2:50 pm

Roche's experimental diabetes drug taspoglutide worked better than a rival drug sold by Eli Lilly & Co. in lowering blood sugar, according to the results of a late stage study.

Read the full article at wsj.com

drugs
medications
roche
pharma
research
byetta
blood sugar
pills
prescriptions

Report this to a moderator

162 views

	jayabee52 October 31 at 12:02 am Decided to do some digging, and found the article without having to subscribel to WSJ & posted it.
	jayabee52 October 30 at 11:38 pm BUMMER! You have to get a subscription to the Wall Street Journal to see more than just the first few lines of the article!

Roche's New Diabetes Drug Works Better Than Byetta

Comments (2 comments) Add your comment